89bio Inc logo

89bio Inc

NEW
NAS:ETNB (USA)   Ordinary Shares
$ 8.67 -0.21 (-2.36%) 02:44 PM EST
At Loss
P/B:
2.60
Enterprise V:
$ 896.12M
Volume:
974.88K
Avg Vol (2M):
2.63M
Trade In:
Volume:
974.88K
At Loss
Avg Vol (2M):
2.63M

Business Description

89bio Inc logo
89bio Inc
NAICS : 325412 SIC : 2834
ISIN : US2825591033

Share Class Description:

ETNB: Ordinary Shares
Description
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
Name Current Vs Industry Vs History
Cash-To-Debt 11.71
Equity-to-Asset 0.84
Debt-to-Equity 0.09
Debt-to-EBITDA -0.1
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.18
Quick Ratio 12.18
Cash Ratio 12.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -67.3
Shareholder Yield % -14.07

Financials (Next Earnings Date:2025-05-09 Est.)

ETNB's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ETNB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

89bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.43
Beta 0.62
3-Year Sharpe Ratio 0.57
3-Year Sortino Ratio 0.96
Volatility % 51.71
14-Day RSI 41.33
14-Day ATR ($) 0.699569
20-Day SMA ($) 10.4615
12-1 Month Momentum % -26.39
52-Week Range ($) 5.9857 - 16.63
Shares Outstanding (Mil) 145.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

89bio Inc Filings

Filing Date Document Date Form
No Filing Data

89bio Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

89bio Inc Frequently Asked Questions

What is 89bio Inc(ETNB)'s stock price today?
The current price of ETNB is $8.67. The 52 week high of ETNB is $16.63 and 52 week low is $5.99.
When is next earnings date of 89bio Inc(ETNB)?
The next earnings date of 89bio Inc(ETNB) is 2025-05-09 Est..
Does 89bio Inc(ETNB) pay dividends? If so, how much?
89bio Inc(ETNB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1